An examination of periodontal treatment and per member per month (PMPM) medical costs in an insured population

被引：0
|
作者：
David A Albert
Donald Sadowsky
Panos Papapanou
Mary L Conicella
Angela Ward
机构：
[1] Columbia University College of Dental Medicine,
[2] Aetna,undefined
来源：
BMC Health Services Research | / 6卷
关键词：
Coronary Artery Disease; Oral Health; Periodontitis; Dental Service; Gingivitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Resource utilization and direct medical costs in adult systemic lupus erythematosus patients from a commercially insured population
    Furst, D. E.
    Clarke, A.
    Fernandes, A. W.
    Bancroft, T.
    Gajria, K.
    Greth, W.
    Iorga, S. R.
    LUPUS, 2013, 22 (03) : 268 - 278
  • [42] Periodontal treatment and subsequent clinical outcomes and medical care costs: A retrospective cohort study
    Michalowicz, Bryan S.
    Anderson, Jeffrey P.
    Kottke, Thomas E.
    Dehmer, Steven P.
    Worley, Donald C.
    Kane, Sheryl
    Basile, Sarah
    Rindal, D. Brad
    PLOS ONE, 2023, 18 (08):
  • [43] Anabolic and Antiresorptive Osteoporosis Treatment: Trends, Costs, and Sequence in a Commercially Insured Population, 2003-2021
    Wadhwa, Harsh
    Wu, Janet Y.
    Lee, Jennifer S.
    Zygourakis, Corinna C.
    JBMR PLUS, 2023, 7 (10)
  • [44] Treatment for substance use disorders in a privately, insured population under managed care: Costs and services use
    Greenfield, SF
    Azzone, V
    Huskamp, H
    Cuffel, B
    Croghan, T
    Goldman, W
    Frank, RG
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2004, 27 (04) : 265 - 275
  • [45] Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population
    Ray, Saurabh
    Bonafede, Machaon M.
    Mohile, Nimish A.
    AMERICAN HEALTH AND DRUG BENEFITS, 2014, 7 (03): : 140 - 149
  • [46] Analysis of Costs per Responder in US Adults with Paroxysmal Nocturnal Hemoglobinuria with a Suboptimal Response to Prior Eculizumab Treatment
    Fishman, Jesse
    Anderson, Seri
    Talbird, Sandra E.
    Dingli, David
    HEMATOLOGY REPORTS, 2023, 15 (04) : 578 - 591
  • [47] Statistical power and optimum sample allocation ratio for treatment and control having unequal costs per unit of randomization
    Liu, XF
    JOURNAL OF EDUCATIONAL AND BEHAVIORAL STATISTICS, 2003, 28 (03) : 231 - 248
  • [48] Relative efficacy and costs per responder for adalimumab versus secuki-numab in the treatment of moderate to severe psoriasis
    Armstrong, April
    Betts, Keith
    Sundaram, Murali
    Li, Junlong
    Wu, Eric
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB267 - AB267
  • [49] The biennial direct pharmaceutical costs per treatment with biologics for the inflammatory bowel disease in Greece: A comparative calculation study
    Liatsos, C.
    Papaefthymiou, A.
    Kyriakos, N.
    Giakoumis, M.
    Tzouvala, M.
    Doulberis, M.
    Mavrogiannis, C.
    Kountouras, J.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S569 - S571
  • [50] Long-term drug costs per life-month gained associated with first-line treatments for unresectable or metastatic melanoma
    Liu J.S.
    Rao S.
    Experimental Hematology & Oncology, 5 (1)
12345